AIUC raises $40 million for AI-agent audit service

Image: Primary

Published Tuesday, September 15, 2026 · 10:07 AM EDT

Artificial Intelligence Underwriting Company, or AIUC, announced a $40 million Series A led by Ribbit Capital, bringing its reported total funding to $55 million. The startup sells AIUC-1, a testing and certification service for AI agents. It says agents are run through about 5,000 tests covering jailbreaks, hallucinations and data leaks, with humans verifying the final audit. AIUC names Cursor, Lovable, Harvey and ElevenLabs as customers.

Sources

TechCrunch

Published by Tech & Business, a media brand covering technology and business. This story was sourced from TechCrunch and reviewed by the T&B editorial agent team.

Back to Newswire

Keep reading

Full wire

AI Products

Amazon sets up supplier financing to borrow as much as $80 billion

Amazon has established supplier financing arrangements to borrow as much as $80 billion against the value of hardware it buys, Bloomberg reported.

AI Infrastructure

Five technology giants commit more than $3T to future spending

Alphabet, Meta, Microsoft, Amazon and Oracle have committed more than $3T to future spending on data centres, leases, equipment and energy, The Next Web reported, citing Bloomberg. Alphabet accounts for more than $1T and Meta for more than $800B.

Security Infrastructure

Linux flaw enables remote root exploit on servers using Multipath TCP

Anthropic researchers demonstrated remote root command execution through CVE-2026-98432 on a Linux server running a Multipath TCP listener, BleepingComputer reported.

Science

Researchers demonstrate faster water transport with more selective membrane

University of Queensland researchers demonstrated a membrane that increased water transport by approximately 44% and reduced ethanol transport by 90% in ethanol-water separation experiments, Phys.org reported.

AI Policy

AI election PAC spending reaches nearly $80M, with regulatory advocates ahead

AI-oriented political action committees spent nearly $80M on the 2026 US elections, mostly before the primaries, Puck reported, citing FEC data.

AI Science

Insilico says AI-discovered Rentosertib has entered Phase III trials

Insilico Medicine says Rentosertib, its generative AI-discovered drug candidate also known as ISM001-055, has entered Phase III clinical trials for idiopathic pulmonary fibrosis. The company described the clinical advance in an announcement carried by News-Medical.Net.